News Archive

Developing the Next Generation of Targeted, Conditionally Active Cytokine Therapeutics

LinkedIn

Mar 30, 2023 Blog

A Recipe for Start-Up Success with a Platform Technology

Life Science Leader

Mar 1, 2023 Media

Founder & CEO John Mulligan Shares Bonum Therapeutics’ “No Jerks” Approach to Hiring

LinkedIn

Feb 14, 2023 Blog

6 Tips for Successful Drug Discovery Teamwork

LinkedIn

Dec 16, 2022 Blog

The Busiest Dealmakers of 2022

In Vivo Pharma Intelligence

Dec 1, 2022 Media

Seattle biotech Bonum raises $93M Series A round

Puget Sound Business Journal

Nov 16, 2022 Media

Good Therapeutics spinout Bonum banks $93 million in Series A

The pharmaletter

Nov 16, 2022 Media

Seattle biotech startup born out of a Roche buyout lands $93M to advance therapies

GeekWire

Nov 15, 2022 Media

After $250M Roche buyout, a startup plans a second strike with fresh funding

BioPharmaDive

Nov 15, 2022 Media